NOVONIX Ltd Files 6-K Report
Ticker: NVNXF · Form: 6-K · Filed: Jul 30, 2025 · CIK: 1859795
Sentiment: neutral
Topics: regulatory-filing, 6-K, foreign-private-issuer
Related Tickers: NVX
TL;DR
NOVONIX filed a 6-K, check Exhibit 99.1 for Appendix 2A.
AI Summary
NOVONIX Limited filed a Form 6-K on July 30, 2025, reporting for the month of July 2025. The filing includes Exhibit 99.1, which is Appendix 2A (Application). The company is incorporated in Australia and its fiscal year ends on December 31.
Why It Matters
This filing provides an update on the company's regulatory submissions, which could be relevant for investors tracking its compliance and operational progress.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (Form 6-K) that primarily serves as an update and does not appear to contain significant new financial or operational disclosures.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- July 2025 (date) — Reporting period
- July 30, 2025 (date) — Filing date
- Appendix 2A (Application) (document) — Included exhibit
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date is July 30, 2025.
What period does this Form 6-K report cover?
This Form 6-K reports for the month of July 2025.
What is included in Exhibit 99.1 of this filing?
Exhibit 99.1 is described as 'Appendix 2A (Application)'.
Where is NOVONIX Limited's principal executive office located?
NOVONIX Limited's principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 30, 2025 regarding NOVONIX Ltd (NVNXF).